Turkey is a key destination for breast cancer treatment, with top clinics like Anadolu Medical Center, Memorial Şişli Hospital, and Lokman Hekim Istanbul Hospital. These are accredited by the Joint Commission International. Anadolu Medical Center, linked with Johns Hopkins Medicine, offers targeted therapy, immunotherapy, and robotic surgery. Memorial Şişli Hospital, Turkey's first JCI-accredited, has a 90% transplant success rate and advanced cancer care. Lokman Hekim Istanbul Hospital, certified by TÜV NORD CERT, provides minimally invasive surgeries and advanced radiotherapy.
The breast cancer survival rate in Turkey reaches 85%, comparable to Western countries, with high early-stage treatment success. Innovative procedures include oncoplastic surgery, cryoablation, intraoperative radiotherapy (IORT), and proton therapy, attracting international patients for effective treatment.